Journal ArticleOPEN ACCESS

Recurrence of atrial fibrillation after switching from brand to generic atenolol

Journal of Pharmacology and Pharmacotherapeutics (2015) 6(1) 39-41
DOI: 10.4103/0976-500X.149146
6Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Beta blockers are the initial treatment for rate control of supraventricular tachyarrhythmia in patients without a history of myocardial infarction or left ventricular dysfunction. In this article we report the recurrence of atrial fibrillation after switching to the generic formulation of atenolol.

Author supplied keywords

Cite

CITATION STYLE

APA

Gallelli, L., Maida, F., Staltari, O., Rende, P., Russo, E., Caroleo, B., & De Sarro, G. (2015). Recurrence of atrial fibrillation after switching from brand to generic atenolol. Journal of Pharmacology and Pharmacotherapeutics, 6(1), 39–41. https://doi.org/10.4103/0976-500X.149146

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free